KRT18 and COVID-19: The widely used K18-hACE2 transgenic mouse model expresses the SARS-CoV-2 receptor, human angiotensin-converting enzyme 2 (hACE2) from the keratin 18 promoter, and provides a severe model of COVID-19 [37,38].